Brigham and Women's Hospital/ Harvard Medical School
BOSTON, MA, United States
Karen Costenbader, MD, MPH holds the Michael Weinblatt, MD Distinguished Chair of Rheumatology and is Director of the Lupus Program at Brigham and Women’s Hospital (BWH), and Professor of Medicine at Harvard Medical School. Dr. Costenbader is a clinician and a clinical and translational investigator. Her research investigates the epidemiology and pathogenesis of SLE and RA. Dr. Costenbader is also an active clinical research mentor. She is PI of the BWH Lupus Registry containing data on over 2400 patients with SLE, and has established the BWH Lupus Biobank, used for studies investigating biomarkers, molecular signatures and genetics. She is the current chair of the Medical-Scientific Advisory Council for the Lupus Foundation of America. She serves on grant review committees and is a reviewer for multiple journals.
Saturday, November 16, 2024
9:00 AM – 10:30 AM Eastern Time
Disclosure(s): Bristol-Myers Squibb(BMS): Consultant (Ongoing); Cabaletta: Consultant (Ongoing); Gilead: Grant/Research Support (Ongoing); Glaxo Smith Kline: Consultant (Ongoing); Janssen: Consultant (Ongoing), Grant/Research Support (Ongoing); Merck/MSD: Grant/Research Support (Ongoing)
Saturday, November 16, 2024
10:30 AM – 12:30 PM Eastern Time
No financial relationships with ineligible companies to disclose
Saturday, November 16, 2024
3:00 PM – 3:15 PM Eastern Time
No financial relationships with ineligible companies to disclose
Sunday, November 17, 2024
10:30 AM – 12:30 PM Eastern Time
No financial relationships with ineligible companies to disclose
Reduction in Autoimmunity with Vitamin D and Treatment Effects in Rheumatic Diseases
Monday, November 18, 2024
9:20 AM – 9:40 AM Eastern Time
Disclosure(s): Bristol-Myers Squibb(BMS): Consultant (Ongoing); Cabaletta: Consultant (Ongoing); Gilead: Grant/Research Support (Ongoing); Glaxo Smith Kline: Consultant (Ongoing); Janssen: Consultant (Ongoing), Grant/Research Support (Ongoing); Merck/MSD: Grant/Research Support (Ongoing)
18M25: Meet the Panel: How Can We Rescue Clinical Trials?
Monday, November 18, 2024
10:30 AM – 11:30 AM Eastern Time
Disclosure(s): Bristol-Myers Squibb(BMS): Consultant (Ongoing); Cabaletta: Consultant (Ongoing); Gilead: Grant/Research Support (Ongoing); Glaxo Smith Kline: Consultant (Ongoing); Janssen: Consultant (Ongoing), Grant/Research Support (Ongoing); Merck/MSD: Grant/Research Support (Ongoing)
How Can We Do Better in SLE Trials?
Monday, November 18, 2024
11:15 AM – 11:30 AM Eastern Time
Disclosure(s): Bristol-Myers Squibb(BMS): Consultant (Ongoing); Cabaletta: Consultant (Ongoing); Gilead: Grant/Research Support (Ongoing); Glaxo Smith Kline: Consultant (Ongoing); Janssen: Consultant (Ongoing), Grant/Research Support (Ongoing); Merck/MSD: Grant/Research Support (Ongoing)
Monday, November 18, 2024
11:15 AM – 11:30 AM Eastern Time
Disclosure(s): Bristol-Myers Squibb(BMS): Consultant (Ongoing); Cabaletta: Consultant (Ongoing); Gilead: Grant/Research Support (Ongoing); Glaxo Smith Kline: Consultant (Ongoing); Janssen: Consultant (Ongoing), Grant/Research Support (Ongoing); Merck/MSD: Grant/Research Support (Ongoing)